Rare disease patient groups as clinical researchers

Ginger R Polich1

  • 1ginger.polich@ucsf.edu

Drug Discovery Today
|October 22, 2011
PubMed

Insights

Rare disease patients are becoming citizen scientists, generating valuable research data and hypotheses through online networks. Patient-led research, while needing oversight, shows promise for advancing rare disease therapies.

Area of Science:

  • Patient-driven research
  • Rare disease studies
  • Citizen science in medicine

Background:

  • Inadequate treatments for rare diseases necessitate novel research approaches.
  • Patients are increasingly self-organizing to understand and manage their conditions.
  • Online platforms facilitate the collection and sharing of patient experiences.

Purpose of the Study:

  • To explore the process and implications of patient-driven research in rare diseases.
  • To analyze how patient groups generate research data and hypotheses.
  • To assess the potential of patient groups as a research resource.

Main Methods:

  • Analysis of patient-led initiatives in rare disease communities.
  • Examination of data collection and hypothesis generation by patient groups.
  • Review of therapeutic anecdotes and self-testing outcomes shared online.

Main Results:

  • Patient groups effectively transform personal experiences into research data.
  • Preliminary research hypotheses are developed and shared with professionals.
  • Patient efforts have contributed to evaluating new therapeutic modalities.

Conclusions:

  • Patient-driven research is a growing trend with significant potential.
  • Collaboration between patient groups, academia, and industry can accelerate rare disease research.
  • Methodological quality and patient safety require careful consideration in patient-led studies.

Related Concept Videos

Case Studies01:22

Case Studies

There are many research methods available to psychologists in their efforts to understand, describe, and explain behavior and the cognitive and biological processes that underlie it.
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...